The Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC.
Can J Surg. 2014 Apr;57(2):127-38. doi: 10.1503/cjs.022412.
Rectal adenomas and cancers occur frequently. Small adenomas can be removed colonoscopically, whereas larger polyps are removed via conventional transanal excision. Owing to technical difficulties, adenomas of the mid- and upper rectum require radical resection. Transanal endoscopic microsurgery (TEM) was first designed as an alternative treatment for these lesions. However, since its development TEM has been also used for a variety of rectal lesions, including carcinoids, rectal prolapse and diverticula, early stage carcinomas and palliative resection of rectal cancers. The objective of this review is to describe the current status of TEM in the treatment of rectal lesions. Since the 1980s, TEM has advanced substantially. With low recurrence rates, it is the method of choice for resection of endoscopically unresectable adenomas. Some studies have shown benefits to its use in treating early T1 rectal cancers compared with radical surgery in select patients. However, for more advanced rectal cancers TEM should be considered palliative or experimental. This technique has also been shown to be safe for the treatment of other uncommon rectal tumours, such as carcinoids. Transanal endoscopic microsurgery may allow for new strategies in the treatment of rectal pathology where technical limitations of transanal techniques have limited endoluminal surgical innovations.
直肠腺瘤和癌症很常见。小腺瘤可通过结肠镜切除,而较大的息肉则通过传统的经肛门切除。由于技术上的困难,中、上段直肠的腺瘤需要根治性切除。经肛门内镜微创手术(TEM)最初被设计为这些病变的替代治疗方法。然而,自其发展以来,TEM 也被用于治疗各种直肠病变,包括类癌、直肠脱垂和憩室、早期癌和直肠癌的姑息性切除。本综述的目的是描述 TEM 在直肠病变治疗中的现状。自 20 世纪 80 年代以来,TEM 取得了很大进展。由于复发率低,它是切除内镜不可切除的腺瘤的首选方法。一些研究表明,与选择性患者的根治性手术相比,TEM 在治疗早期 T1 直肠癌方面具有优势。然而,对于更晚期的直肠癌,TEM 应被视为姑息性或实验性的。该技术对于治疗其他罕见的直肠肿瘤如类癌也安全。经肛门内镜微创手术可能为直肠病变的治疗提供新的策略,因为经肛门技术的技术限制限制了腔内手术的创新。